Orphenadrine Citrate, Aspirin and Caffeine
- Product NDC
- 74157-999
- 11-digit product format
- 741570999
- Labeler code
- 74157
- Product ID
- 74157-999_d2aca771-3b03-41a1-e053-2995a90acb50
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- orphenadrine citrate, aspirin and caffeine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- INA Pharmaceutics, Inc
- Application
- ANDA075141
- Marketing category
- ANDA
- Marketing start
- 2020-05-27
- Marketing end
- 0000-00-00
- Substance
- ORPHENADRINE CITRATE; ASPIRIN; CAFFEINE
- Active strength
- 50 mg/1; mg/1; mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC],Central Nervous System Stimulant [EPC],Methylxanthine [EPC],Xanthines [CS],Central Nervous System Stimulation [PE]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 74157-999-60 | 74157099960 | 60 TABLET in 1 BOTTLE, PLASTIC (74157-999-60) | 60 tablet | 2020-05-27 | 0000-00-00 | No | No | Current |